Wire Sciences Medical Technology (Suzhou) Co., Ltd announced that it has entered into a capital increase agreement for private placement of common shares on January 17, 2022. The transaction will include participation from new investor Zylox-Tonbridge Medical Technology Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd.
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.68 HKD | +1.71% | +3.29% | -14.15% |
03-22 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
03-21 | Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.15% | 448M | |
+9.68% | 125B | |
-7.58% | 10.91B | |
+2.17% | 8.93B | |
+22.75% | 7.57B | |
+33.99% | 5.36B | |
+8.12% | 3.43B | |
-8.48% | 2.81B | |
-5.07% | 2.23B | |
-4.22% | 2.13B |
- Stock Market
- Equities
- 2190 Stock
- News Zylox-Tonbridge Medical Technology Co., Ltd.
- Wire Sciences Medical Technology Co., Ltd announced that it expects to receive funding from Zylox-Tonbridge Medical Technology Co., Ltd.